takeaway from the media release:
"the Company has just now started into its second year of commercial operations. Salesare tracking expectations..."
Printable View
takeaway from the media release:
"the Company has just now started into its second year of commercial operations. Salesare tracking expectations..."
Oh phew, not everyone on this thread who comments is banned yet :-S
"US Sales are tracking expectations following acceptance of Cxbladder as an adjunct technology by four national provider networks and an active marketing program to clinicians and healthcare organisations."
Most interesting thing in the announcement.
I haven't had a direct reply to my request - they must have been too busy preparing today's announcement. That will do in the meantime.
The FY15 financials will be revealed late May so patience required for the next few months while they count the money that appears to be starting to come in from the US market.
Maybe the product line up is Ok and the (former) doom & gloom merchants on PEB might be proved wrong.
Analyst consensus is for $3.2M revenues (+278%) for the full year to 31 March up from $0.8M in the prior year.
https://au.finance.yahoo.com/q/ae?s=PEB.NZ
Ok thanks. Has the company announced any of their own forecasts?
If I was PEB management --This is exactly what I would do at this stage(announcement)
The patent (which they jumped the gun on before)is a great way to throw in some hints on sales (whether the goods are there or not)